Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Conrad P Hodgkinson

Showing results (1-10 of 58) with videos related to

Pageof 6
Sort By:
Pharmacogenetics and Genomics|August 14, 2008
Statins inhibit toll-like receptor 4-mediated lipopolysaccharide signaling and cytokine expressionConrad P Hodgkinson, Shu Ye
Thescientificworldjournal|February 22, 2011
Toll-like receptors, their ligands, and atherosclerosisConrad P Hodgkinson, Shu Ye
Biochemical and Biophysical Research Communications|August 14, 2003
Microarray analysis of peroxisome proliferator-activated receptor-gamma induced changes in gene expression in macrophagesConrad P Hodgkinson, Shu Ye
Biochemistry|January 10, 2002
Regulation of both PDK1 and the phosphorylation of PKC-zeta and -delta by a C-terminal PRK2 fragmentConrad P Hodgkinson, Graham J Sale
Biochemistry and Biophysics Reports|July 21, 2022
Conservation of miR combo based direct cardiac reprogrammingSyeda Samara Baksh, Conrad P Hodgkinson
Circulation|February 26, 2024
RNA Therapeutics for the Cardiovascular SystemVictor J Dzau, Conrad P Hodgkinson
American Journal of Physiology. Heart and Circulatory Physiology|March 10, 2023
Loss of PLCε activity as a culprit of ascending aortic dilation and aortic aneurysmConrad P Hodgkinson, Jose A Gomez
Circulation Research|March 28, 2015
Conserved microRNA program as key to mammalian cardiac regeneration: insights from zebrafishConrad P Hodgkinson, Victor J Dzau
Hypertension (Dallas, Tex. : 1979)|December 19, 2023
Precision HypertensionVictor J Dzau, Conrad P Hodgkinson
Molecular Therapy. Nucleic Acids|January 15, 2024
miRNAs to the rescue: Reversing heart failure by targeting miR-29Xinghua Wang, Iqra Anwar, Conrad P Hodgkinson
Pageof 6

Showing results (1-10 of 58) with videos related to

Sort By:
Pageof 6
Pharmacogenetics and Genomics|August 14, 2008
Statins inhibit toll-like receptor 4-mediated lipopolysaccharide signaling and cytokine expressionConrad P Hodgkinson, Shu Ye
Thescientificworldjournal|February 22, 2011
Toll-like receptors, their ligands, and atherosclerosisConrad P Hodgkinson, Shu Ye
Biochemical and Biophysical Research Communications|August 14, 2003
Microarray analysis of peroxisome proliferator-activated receptor-gamma induced changes in gene expression in macrophagesConrad P Hodgkinson, Shu Ye
Biochemistry|January 10, 2002
Regulation of both PDK1 and the phosphorylation of PKC-zeta and -delta by a C-terminal PRK2 fragmentConrad P Hodgkinson, Graham J Sale
Biochemistry and Biophysics Reports|July 21, 2022
Conservation of miR combo based direct cardiac reprogrammingSyeda Samara Baksh, Conrad P Hodgkinson
Circulation|February 26, 2024
RNA Therapeutics for the Cardiovascular SystemVictor J Dzau, Conrad P Hodgkinson
American Journal of Physiology. Heart and Circulatory Physiology|March 10, 2023
Loss of PLCε activity as a culprit of ascending aortic dilation and aortic aneurysmConrad P Hodgkinson, Jose A Gomez
Circulation Research|March 28, 2015
Conserved microRNA program as key to mammalian cardiac regeneration: insights from zebrafishConrad P Hodgkinson, Victor J Dzau
Hypertension (Dallas, Tex. : 1979)|December 19, 2023
Precision HypertensionVictor J Dzau, Conrad P Hodgkinson
Molecular Therapy. Nucleic Acids|January 15, 2024
miRNAs to the rescue: Reversing heart failure by targeting miR-29Xinghua Wang, Iqra Anwar, Conrad P Hodgkinson
Pageof 6